- Tools
- Downloads
- Links
- Community
- About
- Help
FB2026_01
,
released March 12, 2026
[16F7-16F7];[17A8-17A8];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
16F7;17A8
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Df(1)BSC352 fails to complement Df(1)oso.
Dominantly modifies the size of pupae relative to wild-type controls.
The presence of P+PBac{XP5.WH5}BSC352 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of PBac{WH}f06492 to be at Release 3 genomic coordinate 17848426 on chromosome 1. This corresponds to 16F7 on both the Release 3 and 5 genome maps. The predicted position of P{XP}CrebB-17Ad01424 on the Release 5 map is 17A8. Consequently, the cytological breakpoints of Df(1)BSC352 are predicted to be 16F7;17A8.